EPISODE · Oct 24, 2024 · 19 MIN
Transcriptional regulation in disease: opportunities, challenges, and the future
from The Studio at Kendall Square · host BiotechTV
Cigall Kadoch, associate professor and HHMI Investigator, Dana-Farber Cancer Institute and Harvard Medical School, and scientific founder of Foghorn Therapeutics (NASDAQ: FHTX), interviews Rick Young, professor of biology at MIT and member of the Whitehead Institute about the latest research and knowledge of how transcriptional regulation can be harnessed and targeted in drug development.
What this episode covers
Cigall Kadoch, associate professor and HHMI Investigator, Dana-Farber Cancer Institute and Harvard Medical School, and scientific founder of Foghorn Therapeutics (NASDAQ: FHTX), interviews Rick Young, professor of biology at MIT and member of the Whitehead Institute about the latest research and knowledge of how transcriptional regulation can be harnessed and targeted in drug development.
NOW PLAYING
Transcriptional regulation in disease: opportunities, challenges, and the future
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m